First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

Summary

This is a phase 1 safety study performed in male or female adult participants with an established diagnosis of severe to profound sensorineural hearing loss that meets the criteria for cochlear implantation and the participant has already chosen to undergo cochlear implant surgery.

Timeline

Start

2017-05-30

Primary completion

2017-12-12

Completion

2018-01-18

Drugs

Indications